Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
205.57
-2.31 (-1.11%)
At close: Aug 31, 2026, 4:00 PM EDT
205.80
+0.23 (0.11%)
After-hours: Aug 31, 2026, 7:58 PM EDT
Revolution Medicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $240 → $275 | Buy | Reiterates | $240 → $275 | +33.77% | Aug 31, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $291 → $315 | Buy | Maintains | $291 → $315 | +53.23% | Aug 29, 2026 |
| UBS | UBS | Buy Maintains $220 → $265 | Buy | Maintains | $220 → $265 | +28.91% | Aug 28, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $215 | Buy | Maintains | $215 | +4.59% | Aug 27, 2026 |
| Jefferies | Jefferies | Buy Maintains $270 | Buy | Maintains | $270 | +31.34% | Aug 27, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $227 → $246 | Buy | Reiterates | $227 → $246 | +19.67% | Aug 27, 2026 |
| Raymond James | Raymond James | Buy Maintains $230 → $248 | Buy | Maintains | $230 → $248 | +20.64% | Aug 27, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $230 → $260 | Buy | Maintains | $230 → $260 | +26.48% | Aug 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.